RE:RE:RE:RE:RE:RE:It occurs to me I don't know what your problem is TheeRock but THRM has been very clear on their results. In fact the results as presented on their website are conservative compared to what they appear to have achieved recently. If you were to look, which you're not, at all the evidence both with THRM and those countries that have enbraced rapid antigen testing, you would see that THRM is on track to leave behind multilple companies that have promised much and delivered litte.
I have no idea Why you're here? Maybe to save us froim our mistakes??? Do you actually own any shares?
TheeRook wrote: THRm ACUVid is still missing the Limit of Detection, PERFORMANCE CHARACTERISTICS and CLINICAL PERFORMANCE data from their published information.
Take a look at the FDa Approved BinaxNOW™ COVID-19 Ag Card to see what is missing.
https://www.fda.gov/media/141570/download TheeRook wrote: Approval. Each country has their own Medical Device Authority (MDA)
Even in Malayasia what they make has to be approved before commercial sale.
Bakunin6 wrote: Im thinking they're going to start making them now for asian distribution.
If it works, it works...why wouldn't they?
what's stopping them?